z-logo
Premium
Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome–Hirschsprung disease association
Author(s) -
Arnold Stacey,
Pelet Anna,
Amiel Jeanne,
Borrego Salud,
Hofstra Robert,
Tam Paul,
Ceccherini Isabella,
Lyonnet Stanislas,
Sherman Stephanie,
Chakravarti Aravinda
Publication year - 2009
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.20944
Subject(s) - biology , genetics , allele , hirschsprung's disease , enhancer , chromosome , chromosome 21 , genetic association , disease , population , transmission disequilibrium test , chromosome 9 , gene , single nucleotide polymorphism , medicine , genotype , gene expression , haplotype , environmental health
Individuals with Down syndrome (DS) display a 40‐fold greater risk of Hirschsprung disease (HSCR) than the general population of newborns implicating chromosome 21 in HSCR etiology. Here we demonstrate that the RET enhancer polymorphism RET +9.7 (rs2435357:C>T) at chromosome 10q11.2 is associated with HSCR in DS individuals both by transmission disequilibrium ( P =0.0015) and case–control ( P =0.0115) analysis of matched cases. Interestingly, the RET +9.7 T allele frequency is significantly different between individuals with DS alone (0.26±0.04), HSCR alone (0.61±0.04), and those with HSCR and DS (0.41±0.04), demonstrating an association and interaction between RET and chromosome 21 gene dosage. This is the first report of a genetic interaction between a common functional variant (rs2435357) and a not infrequent copy number error (chromosome 21 dosage) in two human developmental disorders. Hum Mutat 30:1–5, 2009. © 2009 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom